Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain

A cross-sectional study

Angela Domínguez, Núria Soldevila, Diana Toledo, Pere Godoy, Núria Torner, Luis Force, Jesús Castilla, José María Mayoral, Sonia Tamames, Vicente Martín, Mikel Egurrola, Francisco Sanz, Jenaro Astray, PI12/02079 Working Group Project PI12/02079 Working Group, J. Díaz-Borrego, A. Morillo, M. J. Pérez-Lozano, J. Gutiérrez, M. Pérez-Ruiz, M. A. Fernández-Sierra & 35 others S. Rojo-Rello, R. Ortiz de Lejarazu, M. I. Fernández-Natal, T. Fernández-Villa, A. Pueyo, A. Vilella, A. Antón, G. Navarro, M. Riera, E. Espejo, M. D. Mas, R. Pérez, J. A. Cayla, C. Rius, I. Crespo, C. Izquierdo, R. Torra, M. F. Domínguez-Berjon, M. A. Gutiérrez, S. Jiménez, E. Gil, F. Martín, R. Génova-Maleras, M. C. Prados, F. Ezzine de Blas, J. C. Galan, E. Navas, L. Rodríguez, C. J. Álvarez, E. Banderas, J. Chamorro, I. Casado, J. Díaz, M. J. López de Goicoechea, M. Morales

Research output: Contribution to journalArticle

Abstract

ABSTRACT: Vaccination of the elderly is an important factor in limiting the impact of pneumonia in the community. The aim of this study was to investigate the factors associated with pneumococcal polysaccharide vaccination in patients aged ≥ 65 years hospitalized for causes unrelated to pneumonia, acute respiratory disease, or influenza-like illness in Spain. We made a cross-sectional study during 2013-2014. A bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking into account sociodemographic variables and risk medical conditions. A multivariate analysis was performed using multilevel regression models. 921 patients were included; 403 (43.8%) had received the pneumococcal vaccine (394 received the polysaccharide vaccine). Visiting the general practitioner ≥ 3 times during the last year (OR = 1.79; 95% CI 1.25-2.57); having received the influenza vaccination in the 2013-14 season (OR = 2.57; 95% CI 1.72-3.84) or in any of the 3 previous seasons (OR = 11.70; 95% CI 7.42-18.45) were associated with receiving the pneumococcal polysaccharide vaccine. Pneumococcal vaccination coverage of hospitalized elderly people is low. The elderly need to be targeted about pneumococcal vaccination and activities that encourage healthcare workers to proactively propose vaccination might be useful. Educational campaigns aimed at the elderly could also help to increase vaccination coverages and reduce the burden of pneumococcal disease in the community.

Original languageEnglish (US)
Pages (from-to)1891-1899
Number of pages9
JournalHuman Vaccines and Immunotherapeutics
Volume12
Issue number7
DOIs
StatePublished - Jul 2 2016
Externally publishedYes

Fingerprint

Spain
Polysaccharides
Vaccination
Cross-Sectional Studies
Pneumococcal Vaccines
Human Influenza
Pneumonia
Acute Disease
General Practitioners
Vaccines
Multivariate Analysis
Delivery of Health Care

Keywords

  • elderly patients
  • immunization
  • pneumococcal vaccination
  • public health
  • vaccination

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain : A cross-sectional study. / Domínguez, Angela; Soldevila, Núria; Toledo, Diana; Godoy, Pere; Torner, Núria; Force, Luis; Castilla, Jesús; Mayoral, José María; Tamames, Sonia; Martín, Vicente; Egurrola, Mikel; Sanz, Francisco; Astray, Jenaro; Project PI12/02079 Working Group, PI12/02079 Working Group; Díaz-Borrego, J.; Morillo, A.; Pérez-Lozano, M. J.; Gutiérrez, J.; Pérez-Ruiz, M.; Fernández-Sierra, M. A.; Rojo-Rello, S.; Ortiz de Lejarazu, R.; Fernández-Natal, M. I.; Fernández-Villa, T.; Pueyo, A.; Vilella, A.; Antón, A.; Navarro, G.; Riera, M.; Espejo, E.; Mas, M. D.; Pérez, R.; Cayla, J. A.; Rius, C.; Crespo, I.; Izquierdo, C.; Torra, R.; Domínguez-Berjon, M. F.; Gutiérrez, M. A.; Jiménez, S.; Gil, E.; Martín, F.; Génova-Maleras, R.; Prados, M. C.; Ezzine de Blas, F.; Galan, J. C.; Navas, E.; Rodríguez, L.; Álvarez, C. J.; Banderas, E.; Chamorro, J.; Casado, I.; Díaz, J.; López de Goicoechea, M. J.; Morales, M.

In: Human Vaccines and Immunotherapeutics, Vol. 12, No. 7, 02.07.2016, p. 1891-1899.

Research output: Contribution to journalArticle

Domínguez, A, Soldevila, N, Toledo, D, Godoy, P, Torner, N, Force, L, Castilla, J, Mayoral, JM, Tamames, S, Martín, V, Egurrola, M, Sanz, F, Astray, J, Project PI12/02079 Working Group, PIWG, Díaz-Borrego, J, Morillo, A, Pérez-Lozano, MJ, Gutiérrez, J, Pérez-Ruiz, M, Fernández-Sierra, MA, Rojo-Rello, S, Ortiz de Lejarazu, R, Fernández-Natal, MI, Fernández-Villa, T, Pueyo, A, Vilella, A, Antón, A, Navarro, G, Riera, M, Espejo, E, Mas, MD, Pérez, R, Cayla, JA, Rius, C, Crespo, I, Izquierdo, C, Torra, R, Domínguez-Berjon, MF, Gutiérrez, MA, Jiménez, S, Gil, E, Martín, F, Génova-Maleras, R, Prados, MC, Ezzine de Blas, F, Galan, JC, Navas, E, Rodríguez, L, Álvarez, CJ, Banderas, E, Chamorro, J, Casado, I, Díaz, J, López de Goicoechea, MJ & Morales, M 2016, 'Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study', Human Vaccines and Immunotherapeutics, vol. 12, no. 7, pp. 1891-1899. https://doi.org/10.1080/21645515.2016.1149661
Domínguez, Angela ; Soldevila, Núria ; Toledo, Diana ; Godoy, Pere ; Torner, Núria ; Force, Luis ; Castilla, Jesús ; Mayoral, José María ; Tamames, Sonia ; Martín, Vicente ; Egurrola, Mikel ; Sanz, Francisco ; Astray, Jenaro ; Project PI12/02079 Working Group, PI12/02079 Working Group ; Díaz-Borrego, J. ; Morillo, A. ; Pérez-Lozano, M. J. ; Gutiérrez, J. ; Pérez-Ruiz, M. ; Fernández-Sierra, M. A. ; Rojo-Rello, S. ; Ortiz de Lejarazu, R. ; Fernández-Natal, M. I. ; Fernández-Villa, T. ; Pueyo, A. ; Vilella, A. ; Antón, A. ; Navarro, G. ; Riera, M. ; Espejo, E. ; Mas, M. D. ; Pérez, R. ; Cayla, J. A. ; Rius, C. ; Crespo, I. ; Izquierdo, C. ; Torra, R. ; Domínguez-Berjon, M. F. ; Gutiérrez, M. A. ; Jiménez, S. ; Gil, E. ; Martín, F. ; Génova-Maleras, R. ; Prados, M. C. ; Ezzine de Blas, F. ; Galan, J. C. ; Navas, E. ; Rodríguez, L. ; Álvarez, C. J. ; Banderas, E. ; Chamorro, J. ; Casado, I. ; Díaz, J. ; López de Goicoechea, M. J. ; Morales, M. / Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain : A cross-sectional study. In: Human Vaccines and Immunotherapeutics. 2016 ; Vol. 12, No. 7. pp. 1891-1899.
@article{3e56bf3667a34790b86f72b399d3f0ec,
title = "Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study",
abstract = "ABSTRACT: Vaccination of the elderly is an important factor in limiting the impact of pneumonia in the community. The aim of this study was to investigate the factors associated with pneumococcal polysaccharide vaccination in patients aged ≥ 65 years hospitalized for causes unrelated to pneumonia, acute respiratory disease, or influenza-like illness in Spain. We made a cross-sectional study during 2013-2014. A bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking into account sociodemographic variables and risk medical conditions. A multivariate analysis was performed using multilevel regression models. 921 patients were included; 403 (43.8{\%}) had received the pneumococcal vaccine (394 received the polysaccharide vaccine). Visiting the general practitioner ≥ 3 times during the last year (OR = 1.79; 95{\%} CI 1.25-2.57); having received the influenza vaccination in the 2013-14 season (OR = 2.57; 95{\%} CI 1.72-3.84) or in any of the 3 previous seasons (OR = 11.70; 95{\%} CI 7.42-18.45) were associated with receiving the pneumococcal polysaccharide vaccine. Pneumococcal vaccination coverage of hospitalized elderly people is low. The elderly need to be targeted about pneumococcal vaccination and activities that encourage healthcare workers to proactively propose vaccination might be useful. Educational campaigns aimed at the elderly could also help to increase vaccination coverages and reduce the burden of pneumococcal disease in the community.",
keywords = "elderly patients, immunization, pneumococcal vaccination, public health, vaccination",
author = "Angela Dom{\'i}nguez and N{\'u}ria Soldevila and Diana Toledo and Pere Godoy and N{\'u}ria Torner and Luis Force and Jes{\'u}s Castilla and Mayoral, {Jos{\'e} Mar{\'i}a} and Sonia Tamames and Vicente Mart{\'i}n and Mikel Egurrola and Francisco Sanz and Jenaro Astray and {Project PI12/02079 Working Group}, {PI12/02079 Working Group} and J. D{\'i}az-Borrego and A. Morillo and P{\'e}rez-Lozano, {M. J.} and J. Guti{\'e}rrez and M. P{\'e}rez-Ruiz and Fern{\'a}ndez-Sierra, {M. A.} and S. Rojo-Rello and {Ortiz de Lejarazu}, R. and Fern{\'a}ndez-Natal, {M. I.} and T. Fern{\'a}ndez-Villa and A. Pueyo and A. Vilella and A. Ant{\'o}n and G. Navarro and M. Riera and E. Espejo and Mas, {M. D.} and R. P{\'e}rez and Cayla, {J. A.} and C. Rius and I. Crespo and C. Izquierdo and R. Torra and Dom{\'i}nguez-Berjon, {M. F.} and Guti{\'e}rrez, {M. A.} and S. Jim{\'e}nez and E. Gil and F. Mart{\'i}n and R. G{\'e}nova-Maleras and Prados, {M. C.} and {Ezzine de Blas}, F. and Galan, {J. C.} and E. Navas and L. Rodr{\'i}guez and {\'A}lvarez, {C. J.} and E. Banderas and J. Chamorro and I. Casado and J. D{\'i}az and {L{\'o}pez de Goicoechea}, {M. J.} and M. Morales",
year = "2016",
month = "7",
day = "2",
doi = "10.1080/21645515.2016.1149661",
language = "English (US)",
volume = "12",
pages = "1891--1899",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",
number = "7",

}

TY - JOUR

T1 - Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain

T2 - A cross-sectional study

AU - Domínguez, Angela

AU - Soldevila, Núria

AU - Toledo, Diana

AU - Godoy, Pere

AU - Torner, Núria

AU - Force, Luis

AU - Castilla, Jesús

AU - Mayoral, José María

AU - Tamames, Sonia

AU - Martín, Vicente

AU - Egurrola, Mikel

AU - Sanz, Francisco

AU - Astray, Jenaro

AU - Project PI12/02079 Working Group, PI12/02079 Working Group

AU - Díaz-Borrego, J.

AU - Morillo, A.

AU - Pérez-Lozano, M. J.

AU - Gutiérrez, J.

AU - Pérez-Ruiz, M.

AU - Fernández-Sierra, M. A.

AU - Rojo-Rello, S.

AU - Ortiz de Lejarazu, R.

AU - Fernández-Natal, M. I.

AU - Fernández-Villa, T.

AU - Pueyo, A.

AU - Vilella, A.

AU - Antón, A.

AU - Navarro, G.

AU - Riera, M.

AU - Espejo, E.

AU - Mas, M. D.

AU - Pérez, R.

AU - Cayla, J. A.

AU - Rius, C.

AU - Crespo, I.

AU - Izquierdo, C.

AU - Torra, R.

AU - Domínguez-Berjon, M. F.

AU - Gutiérrez, M. A.

AU - Jiménez, S.

AU - Gil, E.

AU - Martín, F.

AU - Génova-Maleras, R.

AU - Prados, M. C.

AU - Ezzine de Blas, F.

AU - Galan, J. C.

AU - Navas, E.

AU - Rodríguez, L.

AU - Álvarez, C. J.

AU - Banderas, E.

AU - Chamorro, J.

AU - Casado, I.

AU - Díaz, J.

AU - López de Goicoechea, M. J.

AU - Morales, M.

PY - 2016/7/2

Y1 - 2016/7/2

N2 - ABSTRACT: Vaccination of the elderly is an important factor in limiting the impact of pneumonia in the community. The aim of this study was to investigate the factors associated with pneumococcal polysaccharide vaccination in patients aged ≥ 65 years hospitalized for causes unrelated to pneumonia, acute respiratory disease, or influenza-like illness in Spain. We made a cross-sectional study during 2013-2014. A bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking into account sociodemographic variables and risk medical conditions. A multivariate analysis was performed using multilevel regression models. 921 patients were included; 403 (43.8%) had received the pneumococcal vaccine (394 received the polysaccharide vaccine). Visiting the general practitioner ≥ 3 times during the last year (OR = 1.79; 95% CI 1.25-2.57); having received the influenza vaccination in the 2013-14 season (OR = 2.57; 95% CI 1.72-3.84) or in any of the 3 previous seasons (OR = 11.70; 95% CI 7.42-18.45) were associated with receiving the pneumococcal polysaccharide vaccine. Pneumococcal vaccination coverage of hospitalized elderly people is low. The elderly need to be targeted about pneumococcal vaccination and activities that encourage healthcare workers to proactively propose vaccination might be useful. Educational campaigns aimed at the elderly could also help to increase vaccination coverages and reduce the burden of pneumococcal disease in the community.

AB - ABSTRACT: Vaccination of the elderly is an important factor in limiting the impact of pneumonia in the community. The aim of this study was to investigate the factors associated with pneumococcal polysaccharide vaccination in patients aged ≥ 65 years hospitalized for causes unrelated to pneumonia, acute respiratory disease, or influenza-like illness in Spain. We made a cross-sectional study during 2013-2014. A bivariate analysis was performed comparing vaccinated and unvaccinated patients, taking into account sociodemographic variables and risk medical conditions. A multivariate analysis was performed using multilevel regression models. 921 patients were included; 403 (43.8%) had received the pneumococcal vaccine (394 received the polysaccharide vaccine). Visiting the general practitioner ≥ 3 times during the last year (OR = 1.79; 95% CI 1.25-2.57); having received the influenza vaccination in the 2013-14 season (OR = 2.57; 95% CI 1.72-3.84) or in any of the 3 previous seasons (OR = 11.70; 95% CI 7.42-18.45) were associated with receiving the pneumococcal polysaccharide vaccine. Pneumococcal vaccination coverage of hospitalized elderly people is low. The elderly need to be targeted about pneumococcal vaccination and activities that encourage healthcare workers to proactively propose vaccination might be useful. Educational campaigns aimed at the elderly could also help to increase vaccination coverages and reduce the burden of pneumococcal disease in the community.

KW - elderly patients

KW - immunization

KW - pneumococcal vaccination

KW - public health

KW - vaccination

UR - http://www.scopus.com/inward/record.url?scp=84963509895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963509895&partnerID=8YFLogxK

U2 - 10.1080/21645515.2016.1149661

DO - 10.1080/21645515.2016.1149661

M3 - Article

VL - 12

SP - 1891

EP - 1899

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 7

ER -